10-QFiled Nov 17, 7:00 PM ET

Drugs Made In America Acquisition II Corp. 10-Q

$DMII · Drugs Made In America Acquisition II Corp.

View full filing

Summary not available

This filing does not have a generated research summary. You can still open the original filing and its exhibits.

Documents

ea0265078-10q_drugs2.htmPrimary
QUARTERLY REPORT
ea026507801ex31-1_drugs2.htm
CERTIFICATION
ea026507801ex31-2_drugs2.htm
CERTIFICATION
ea026507801ex32-1_drugs2.htm
CERTIFICATION
ea026507801ex32-2_drugs2.htm
CERTIFICATION
dmaau-20250930.xsd
XBRL SCHEMA FILE
dmaau-20250930_cal.xml
XBRL CALCULATION FILE
dmaau-20250930_def.xml
XBRL DEFINITION FILE
dmaau-20250930_lab.xml
XBRL LABEL FILE
dmaau-20250930_pre.xml
XBRL PRESENTATION FILE
R1.htm
IDEA: XBRL DOCUMENT
R2.htm
IDEA: XBRL DOCUMENT
R3.htm
IDEA: XBRL DOCUMENT
R4.htm
IDEA: XBRL DOCUMENT
R5.htm
IDEA: XBRL DOCUMENT
R6.htm
IDEA: XBRL DOCUMENT
R7.htm
IDEA: XBRL DOCUMENT
R8.htm
IDEA: XBRL DOCUMENT
R9.htm
IDEA: XBRL DOCUMENT
R10.htm
IDEA: XBRL DOCUMENT
R11.htm
IDEA: XBRL DOCUMENT
R12.htm
IDEA: XBRL DOCUMENT
R13.htm
IDEA: XBRL DOCUMENT
R14.htm
IDEA: XBRL DOCUMENT
R15.htm
IDEA: XBRL DOCUMENT
R16.htm
IDEA: XBRL DOCUMENT
R17.htm
IDEA: XBRL DOCUMENT
R18.htm
IDEA: XBRL DOCUMENT
R19.htm
IDEA: XBRL DOCUMENT
R20.htm
IDEA: XBRL DOCUMENT
R21.htm
IDEA: XBRL DOCUMENT
R22.htm
IDEA: XBRL DOCUMENT
R23.htm
IDEA: XBRL DOCUMENT
R24.htm
IDEA: XBRL DOCUMENT
R25.htm
IDEA: XBRL DOCUMENT
R26.htm
IDEA: XBRL DOCUMENT
R27.htm
IDEA: XBRL DOCUMENT
R28.htm
IDEA: XBRL DOCUMENT
R29.htm
IDEA: XBRL DOCUMENT
R30.htm
IDEA: XBRL DOCUMENT
R31.htm
IDEA: XBRL DOCUMENT
R32.htm
IDEA: XBRL DOCUMENT
R33.htm
IDEA: XBRL DOCUMENT
R34.htm
IDEA: XBRL DOCUMENT
R35.htm
IDEA: XBRL DOCUMENT
R36.htm
IDEA: XBRL DOCUMENT
R37.htm
IDEA: XBRL DOCUMENT
Show.js
IDEA: XBRL DOCUMENT
report.css
IDEA: XBRL DOCUMENT
FilingSummary.xml
IDEA: XBRL DOCUMENT
MetaLinks.json
IDEA: XBRL DOCUMENT
0001213900-25-112095-xbrl.zip
IDEA: XBRL DOCUMENT
ea0265078-10q_drugs2_htm.xml
IDEA: XBRL DOCUMENT

Filing details

Company: Drugs Made In America Acquisition II Corp.
CIK: 0002040475
Form: 10-Q
Filed: Nov 17, 7:00 PM ET
Accepted: Nov 18, 4:06 PM ET
Size: 3.5 MB
Accession: 0001213900-25-112095